Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Assessment of the Atrophogenic Potential of Triple Combination Cream Using Histology Measures in the Treatment of Moderate to Severe Melasma

NCT00469183 is registered in ClinicalTrials.gov with Galderma R&D as lead sponsor.

NCT NCT00469183
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00469183 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Assessment of the Atrophogenic Potential of Triple Combination Cream Using Histology Measures in the Treatment of Moderate to Severe Melasma
Lead sponsor
Galderma R&D
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2006
Completion date
April 30, 2007
Enrollment
70 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

melasma